Connect News Commercial Real Estate news for every market and every facet, every day.
Connect CRE Events Live and virtual events bringing together the best of information and networking.
CRE Industry Events Live industry events.
Connect Creative A full service marketing and PR agency.
Connect Classroom Offering CRE focused continuing education courses on demand.
ApartmentBuildings.com Is a dynamic platform to search for, list and promote multifamily listings nationwide.
Connect Awards View the A-list of commercial real estate & submit nominations.
Connect Media Kit Advertise, Promote, Attend, Create – Work with Connect.
Loantuitive Find the right lender for your loan.
About Connect Meet the team behind the machine and taste a little of the secret sauce.
Connect News

Your source for daily news covering CRE transactions and trends. Stay informed on national, regional and property sector news that matters to your business.

Connect Classroom

Offering on-demand online courses that provide continuing education credits for brokers, attorneys, appraisers and architects. Select from easily accessible video and written courses that cover a variety of CRE topics.

Find Your Course
High-rise commercial buildings

STAY INFORMED

News when you need it. All our Breaking News, right to your inbox.

Sub Markets

Property Sectors

Topics

Texas CRE News In Your Inbox.

Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.

Texas  + State of Texas  + Healthcare  |  August 23, 2021
Dialectics
Lisa Brown
By: Lisa Brown

Dialectic Therapeutics Receives $14M Cancer Research Award

A Texas-based biotech firm focused on cancer treatments, Dialectic Therapeutics Inc., recently received a $14.4 million Texas Company (TXCO) Product Development Research Award from the Cancer Prevention and Research Institute of Texas (CPRIT). Dialectic will use the funding to further advance the clinical development of its lead product candidate, DT2216, a unique compound built using the Antiapoptotic Protein Targeted Degradation (APTaD) technology platform.

This grant adds to the initial $3 million seed award that Dialectic received from CPRIT in 2020, which was instrumental in supporting preclinical studies. These studies demonstrate that DT2216 selectively induces the degradation of B-cell lymphoma extra-large or BCL-XL in cancer cells. This either stimulates the return of cellular apoptosis or sensitizes the cells to be more susceptible to chemotherapy and thus cellular destruction.

Connect

Inside The Story

Dialectic Therapeutics Inc.

About Lisa Brown

Lisa Brown has decades of experience in corporate communications and marketing management with organizations including Coldwell Banker Residential, Grubb & Ellis, Marcus & Millichap, NAIOP, SIOR and ALM. In those positions, she worked in conjunction with chief executive officers and chief marketing officers to create corporate messaging, cohesive branding standards, strategic marketing plans and thought pieces. Brown is a frequent speaker at industry events and an editing adjunct professor for an online course. She has a master’s degree in mass communications from San Jose State University.
Order Reprints
  • ◦Financing